© 1996 American Heart Association, Inc.
Articles |
ApoB-100 Secretion by HepG2 Cells Is Regulated by the Rate of Triglyceride Biosynthesis but Not by Intracellular Lipid Pools
the Laboratoire Glaxo Wellcome, Centre de Recherche, Les Ulis, France.
Correspondence to Dr T. Grand-Perret, Laboratoire Glaxo Wellcome, Centre de Recherche, 25 avenue du Quebec, ZA de Courtaboeuf, 91951 Les Ulis cedex, France. E-mail TGP28876@GGR.CO.UK.
Triglycerides (TGs), cholesteryl esters (CEs), cholesterol, and phosphatidylcholine have been independently proposed as playing regulatory roles in apoB-100 secretion; the results depended on the cellular model used. In this study, we reinvestigate the role of lipids in apoB-100 production in HepG2 cells and in particular, we clarify the respective roles of intracellular mass and the biosynthesis of lipids in the regulation of apoB-100 production. In a first set of experiments, the pool size of cholesterol, CEs, and TGs was modulated by a 3-day treatment with either lipid precursors or inhibitors of enzymes involved in lipid synthesis. We used simvastatin (a hydroxymethylglutaryl coenzyme A reductase inhibitor), 58-035 (an acyl coenzyme A cholesterol acyltransferase inhibitor), 5-tetradecyloxy-2-furancarboxylic acid (TOFA, an inhibitor of fatty acid synthesis), and oleic acid. The secretion rate of apoB-100 was not affected by the large modulation of lipid mass induced by these various pretreatments. In a second set of experiments, the same lipid modulators were added during a 4-hour labeling period. Simvastatin and 58-035 inhibited cholesterol and CE synthesis without affecting apoB-100 secretion. By contrast, treatment of HepG2 cells with TOFA resulted in the inhibition of TG synthesis and apoB-100 secretion. This effect was highly specific for apoB-100 and was reversed by adding oleic acid, which stimulated both TG synthesis and apoB-100 secretion. Moreover, a combination of oleic acid and 58-035 inhibited CE biosynthesis and increased both TG synthesis and apoB-100 secretion. These results show that in HepG2 cells TG biosynthesis regulates apoB-100 secretion, whereas the rate of cholesterol or CE biosynthesis has no effect.
Key Words: lipoprotein assembly • cholesteryl ester • hepatocyte • 5-tetradecyloxy-2-furancarboxylic acid
This article has been cited by other articles:
 |
|
 |
|
  A. K. Hihi, M.-C. Beauchamp, R. Branicky, A. Desjardins, I. Casanova, M.-P. Guimond, M. Carroll, M. Ethier, I. Kianicka, K. McBride, et al. Evolutionary conservation of drug action on lipoprotein metabolism-related targets J. Lipid Res., January 1, 2008; 49(1): 74 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Brusq, N. Ancellin, P. Grondin, R. Guillard, S. Martin, Y. Saintillan, and M. Issandou Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine J. Lipid Res., June 1, 2006; 47(6): 1281 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Aspichueta, S. Perez, B. Ochoa, and O. Fresnedo Endotoxin promotes preferential periportal upregulation of VLDL secretion in the rat liver J. Lipid Res., May 1, 2005; 46(5): 1017 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Lewin, S. Wang, C. A. Nagle, C. G. Van Horn, and R. A. Coleman Mitochondrial glycerol-3-phosphate acyltransferase-1 directs the metabolic fate of exogenous fatty acids in hepatocytes Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E835 - E844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Liang, P. Oelkers, C. Guo, P.-C. Chu, J. L. Dixon, H. N. Ginsberg, and S. L. Sturley Overexpression of Human Diacylglycerol Acyltransferase 1, Acyl-CoA:Cholesterol Acyltransferase 1, or Acyl-CoA:Cholesterol Acyltransferase 2 Stimulates Secretion of Apolipoprotein B-containing Lipoproteins in McA-RH7777 Cells J. Biol. Chem., October 22, 2004; 279(43): 44938 - 44944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Ganji, S. Tavintharan, D. Zhu, Y. Xing, V. S. Kamanna, and M. L. Kashyap Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells J. Lipid Res., October 1, 2004; 45(10): 1835 - 1845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-K. Kang, T.-W. Chung, J.-Y. Lee, Y.-C. Lee, R. E. Morton, and C.-H. Kim The Hepatitis B Virus X Protein Inhibits Secretion of Apolipoprotein B by Enhancing the Expression of N-Acetylglucosaminyltransferase III J. Biol. Chem., July 2, 2004; 279(27): 28106 - 28112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M D Robertson, M Parkes, B F Warren, D J P Ferguson, K G Jackson, D P Jewell, and K N Frayn Mobilisation of enterocyte fat stores by oral glucose in humans Gut, June 1, 2003; 52(6): 834 - 839. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. C Chan, G. F Watts, T. A Mori, P H. R Barrett, T. G Redgrave, and L. J Beilin Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity Am. J. Clinical Nutrition, February 1, 2003; 77(2): 300 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Borradaile, L. E. de Dreu, P. H. R. Barrett, and M. W. Huff Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters J. Lipid Res., September 1, 2002; 43(9): 1544 - 1554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Roglans, E. Sanguino, C. Peris, M. Alegret, M. Vazquez, T. Adzet, C. Diaz, G. Hernandez, J. C. Laguna, and R. M. Sanchez Atorvastatin Treatment Induced Peroxisome Proliferator-Activated Receptor alpha Expression and Decreased Plasma Nonesterified Fatty Acids and Liver Triglyceride in Fructose-Fed Rats J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 232 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Rashid, S. Hevi, Y. Chen, F. Le Caherec, and S. L. Chuck A Proteomic Approach Identifies Proteins in Hepatocytes That Bind Nascent Apolipoprotein B J. Biol. Chem., June 7, 2002; 277(24): 22010 - 22017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Chan, G. F. Watts, P. H. R. Barrett, T. A. Mori, L. J. Beilin, and T. G. Redgrave Mechanism of Action of a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor on Apolipoprotein B-100 Kinetics in Visceral Obesity J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2283 - 2289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Plonne, H.-P. Schulze, U. Kahlert, K. Meltke, H. Seidolt, A. J. Bennett, I. J. Cartwright, J. A. Higgins, U. Till, and R. Dargel Postnatal development of hepatocellular apolipoprotein B assembly and secretion in the rat J. Lipid Res., November 1, 2001; 42(11): 1865 - 1878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Elias, B. W. Patterson, and G. Schonfeld In Vivo Metabolism of ApoB, ApoA-I, and VLDL Triglycerides in a Form of Hypobetalipoproteinemia Not Linked to the ApoB Gene Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1309 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Riches, G. F. Watts, J. Hua, G. R. Stewart, R. P. Naoumova, and P. H. R. Barrett Reduction in Visceral Adipose Tissue Is Associated with Improvement in Apolipoprotein B-100 Metabolism in Obese Men J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2854 - 2861. [Abstract] [Full Text]
|
|
|
|
|
|
J. R. Burnett, L. J. Wilcox, D. E. Telford, S. J. Kleinstiver, P. H. R. Barrett, R. S. Newton, and M. W. Huff Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs J. Lipid Res., July 1, 1999; 40(7): 1317 - 1328. [Abstract] [Full Text]
|
|
|
|
|
|
L. J. Wilcox, P. H. R. Barrett, and M. W. Huff Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin J. Lipid Res., June 1, 1999; 40(6): 1078 - 1089. [Abstract] [Full Text]
|
|
|
|
|
|
L. J. Wilcox, P. H. R. Barrett, R. S. Newton, and M. W. Huff ApoB100 Secretion From HepG2 Cells is Decreased by the ACAT Inhibitor CI-1011 : An Effect Associated With Enhanced Intracellular Degradation of ApoB Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 939 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-Y. Jin, V. S. Kamanna, and M. L. Kashyap Niacin Accelerates Intracellular ApoB Degradation by Inhibiting Triacylglycerol Synthesis in Human Hepatoblastoma (HepG2) Cells Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 1051 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhang, K. Cianflone, and A. D. Sniderman Role of Cholesterol Ester Mass in Regulation of Secretion of ApoB100 Lipoprotein Particles by Hamster Hepatocytes and Effects of Statins on That Relationship Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 743 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-M. Brown, D. Wiggins, and G. F. Gibbons Glucose Phosphorylation Is Essential for the Turnover of Neutral Lipid and the Second Stage Assembly of Triacylglycerol-Rich ApoB-Containing Lipoproteins in Primary Hepatocyte Cultures Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 321 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Shelness, M. F. Ingram, X. F. Huang, and J. A. DeLozier Apolipoprotein B in the Rough Endoplasmic Reticulum: Translation, Translocation and the Initiation of Lipoprotein Assembly J. Nutr., February 1, 1999; 129(2): 456 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jiang, H. N. Ginsberg, and X. Wu Glucose does not stimulate apoprotein B secretion from HepG2 cells because of insufficient stimulation of triglyceride synthesis J. Lipid Res., November 1, 1998; 39(11): 2277 - 2285. [Abstract] [Full Text]
|
|
|
|
|
|
J. Luchoomun, Z. Zhou, A. Bakillah, H. Jamil, and M. M. Hussain Assembly and Secretion of VLDL in Nondifferentiated Caco-2 Cells Stably Transfected With Human Recombinant ApoB48 cDNA Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2955 - 2963. [Abstract] [Full Text]
|
|
|
|
|
|
F. Benoist and T. Grand-Perret Co-translational Degradation of Apolipoprotein B100 by the Proteasome Is Prevented by Microsomal Triglyceride Transfer Protein. SYNCHRONIZED TRANSLATION STUDIES ON HepG2 CELLS TREATED WITH AN INHIBITOR OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN J. Biol. Chem., August 15, 1997; 272(33): 20435 - 20442. [Abstract] [Full Text] [PDF]
|
|